FAF
PBYI icon

Fjarde Ap-fonden’s Puma Biotechnology PBYI Stock Holding History

Fjarde Ap-fonden’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,997
Closed -$603K – 630
2015
Q3 		$603K Hold
7,997
– – 0.02% 619
2015
Q2 		$934K Buy
+7,997
New +$1.45M 0.02% 619

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fjarde Ap-fonden's PBYI Position: Q4 2015 in Review

Fjarde Ap-fonden sold out of Puma Biotechnology (PBYI) in Q4 2015, closing a stake of 7,997 shares — an estimated $603K sold.

Fjarde Ap-fonden first reported a position in PBYI in Q2 2015 and held it in 2 quarters. The position peaked at $934K in Q2 2015. 133 funds tracked by Wall St. Rank hold PBYI as of Q4 2015.

  • Fjarde Ap-fonden reported no remaining Puma Biotechnology position as of Q4 2015 after selling out during the quarter.
  • Fjarde Ap-fonden sold 7,997 Puma Biotechnology shares in Q4 2015, an estimated $603K.
  • Fjarde Ap-fonden first reported a position in Puma Biotechnology in Q2 2015 and held it in 2 quarters.
  • Fjarde Ap-fonden's Puma Biotechnology position peaked at $934K in Q2 2015.
  • 133 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2015.

Based on Fjarde Ap-fonden's 13F filing for Q4 2015, filed 19 Jan 2016.